Cargando…
Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis
"Nonallergic rhinopathy" was defined by consensus at a Roundtable conference in December 2008 as "a chronic nasal condition with symptoms that may be perennial, persistent, intermittent or seasonal and/or elicited by recognized triggers." The definition includes a well-recognized...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651016/ https://www.ncbi.nlm.nih.gov/pubmed/24228856 http://dx.doi.org/10.1097/WOX.0b013e3181b2ff8a |
_version_ | 1782269149264740352 |
---|---|
author | Kaliner, Michael A Baraniuk, James N Benninger, Michael S Bernstein, Jonathan A Lieberman, Phil Meltzer, Eli O Naclerio, Robert M Settipane, Russell A Farrar, Judith R |
author_facet | Kaliner, Michael A Baraniuk, James N Benninger, Michael S Bernstein, Jonathan A Lieberman, Phil Meltzer, Eli O Naclerio, Robert M Settipane, Russell A Farrar, Judith R |
author_sort | Kaliner, Michael A |
collection | PubMed |
description | "Nonallergic rhinopathy" was defined by consensus at a Roundtable conference in December 2008 as "a chronic nasal condition with symptoms that may be perennial, persistent, intermittent or seasonal and/or elicited by recognized triggers." The definition includes a well-recognized set of clinical exposures that lead to the symptoms, predominantly congestion, rhinorrhea, and postnasal drip. These clinical characteristics help to identify patients for participation in clinical trials examining the efficacy of treatments for this important disease. The next step is to establish inclusion and exclusion criteria that will provide a framework for the clinical trials. Agreement on study criteria was obtained at the consensus conference by discussion, counterpoint, and compromise. |
format | Online Article Text |
id | pubmed-3651016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | World Allergy Organization |
record_format | MEDLINE/PubMed |
spelling | pubmed-36510162013-07-12 Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis Kaliner, Michael A Baraniuk, James N Benninger, Michael S Bernstein, Jonathan A Lieberman, Phil Meltzer, Eli O Naclerio, Robert M Settipane, Russell A Farrar, Judith R World Allergy Organ J Conference Proceedings "Nonallergic rhinopathy" was defined by consensus at a Roundtable conference in December 2008 as "a chronic nasal condition with symptoms that may be perennial, persistent, intermittent or seasonal and/or elicited by recognized triggers." The definition includes a well-recognized set of clinical exposures that lead to the symptoms, predominantly congestion, rhinorrhea, and postnasal drip. These clinical characteristics help to identify patients for participation in clinical trials examining the efficacy of treatments for this important disease. The next step is to establish inclusion and exclusion criteria that will provide a framework for the clinical trials. Agreement on study criteria was obtained at the consensus conference by discussion, counterpoint, and compromise. World Allergy Organization 2009-08-15 /pmc/articles/PMC3651016/ /pubmed/24228856 http://dx.doi.org/10.1097/WOX.0b013e3181b2ff8a Text en Copyright ©2009 World Allergy Organization; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Conference Proceedings Kaliner, Michael A Baraniuk, James N Benninger, Michael S Bernstein, Jonathan A Lieberman, Phil Meltzer, Eli O Naclerio, Robert M Settipane, Russell A Farrar, Judith R Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis |
title | Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis |
title_full | Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis |
title_fullStr | Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis |
title_full_unstemmed | Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis |
title_short | Consensus Description of Inclusion and Exclusion Criteria for Clinical Studies of Nonallergic Rhinopathy (NAR), Previously Referred to as Vasomotor Rhinitis (VMR), Nonallergic Rhinitis, and/or Idiopathic Rhinitis |
title_sort | consensus description of inclusion and exclusion criteria for clinical studies of nonallergic rhinopathy (nar), previously referred to as vasomotor rhinitis (vmr), nonallergic rhinitis, and/or idiopathic rhinitis |
topic | Conference Proceedings |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651016/ https://www.ncbi.nlm.nih.gov/pubmed/24228856 http://dx.doi.org/10.1097/WOX.0b013e3181b2ff8a |
work_keys_str_mv | AT kalinermichaela consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT baraniukjamesn consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT benningermichaels consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT bernsteinjonathana consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT liebermanphil consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT meltzerelio consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT nacleriorobertm consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT settipanerussella consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis AT farrarjudithr consensusdescriptionofinclusionandexclusioncriteriaforclinicalstudiesofnonallergicrhinopathynarpreviouslyreferredtoasvasomotorrhinitisvmrnonallergicrhinitisandoridiopathicrhinitis |